Mattern Capital Management LLC Has $11.08 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Mattern Capital Management LLC decreased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.3% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 18,942 shares of the healthcare conglomerate’s stock after selling 65 shares during the quarter. UnitedHealth Group comprises about 1.4% of Mattern Capital Management LLC’s portfolio, making the stock its 16th biggest holding. Mattern Capital Management LLC’s holdings in UnitedHealth Group were worth $11,075,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently made changes to their positions in the stock. Vicus Capital increased its position in UnitedHealth Group by 278.5% during the first quarter. Vicus Capital now owns 1,813 shares of the healthcare conglomerate’s stock worth $897,000 after buying an additional 1,334 shares during the last quarter. Brown Miller Wealth Management LLC raised its stake in UnitedHealth Group by 3.8% in the 1st quarter. Brown Miller Wealth Management LLC now owns 5,916 shares of the healthcare conglomerate’s stock valued at $2,926,000 after acquiring an additional 219 shares during the period. Atticus Wealth Management LLC boosted its position in UnitedHealth Group by 71.8% during the first quarter. Atticus Wealth Management LLC now owns 603 shares of the healthcare conglomerate’s stock worth $299,000 after purchasing an additional 252 shares during the period. New Mexico Educational Retirement Board raised its position in shares of UnitedHealth Group by 13.0% in the first quarter. New Mexico Educational Retirement Board now owns 54,720 shares of the healthcare conglomerate’s stock valued at $27,906,000 after purchasing an additional 6,300 shares during the period. Finally, Physician Wealth Advisors Inc. grew its stake in UnitedHealth Group by 74.6% in the 1st quarter. Physician Wealth Advisors Inc. now owns 695 shares of the healthcare conglomerate’s stock valued at $326,000 after buying an additional 297 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the company. Barclays decreased their target price on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 22nd. Wells Fargo & Company boosted their target price on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. KeyCorp assumed coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective for the company. Truist Financial reaffirmed a “buy” rating and set a $625.00 target price (down from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Finally, Royal Bank of Canada reduced their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. Four analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Stock Up 0.7 %

NYSE:UNH opened at $564.56 on Friday. The firm’s 50 day simple moving average is $583.52 and its 200 day simple moving average is $537.96. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $608.63. The company has a market cap of $521.33 billion, a PE ratio of 36.78, a P/E/G ratio of 1.67 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same quarter in the prior year, the firm posted $6.56 EPS. The company’s revenue for the quarter was up 9.2% compared to the same quarter last year. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.49%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.